Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 103

Sort by

Sort Order Select

Journal Articles

Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study

Blood (2025) 146 (Supplement 1): 485.

https://doi.org/10.1182/blood-2025-485

Published: 2025

Journal Articles

The recombinant adjuvant zoster vaccine induces similar immune responses in ruxolitinib-treated patients with myelofibrosis and polycythemia vera

Beatriz Astibia-Mahillo, Valentina Leguizamon, Elena Mateos, Montserrat Torres, Nerea Armenteros, Maria Cristina Luengo-Martínez, Abelardo Fernández-Chávez, Natalia Daza, Miguel Piris-Villaespesa, Javier Lopez Jimenez, Mayte Coiras, Valentín García Gutiérrez

Blood (2025) 146 (Supplement 1): 7273.

https://doi.org/10.1182/blood-2025-7273

Published: 2025

Journal Articles

Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study

Blood (2025) 146 (Supplement 1): 81.

https://doi.org/10.1182/blood-2025-81

Published: 2025

Journal Articles

Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics

Blood (2025) 146 (Supplement 1): 7353.

https://doi.org/10.1182/blood-2025-7353

Published: 2025

Journal Articles

Molecular predictors of anemia response to momelotinib in patients with myelofibrosis: Real-world outcomes from the momgemfin study.

Adrian Segura Diaz, Lucia Perez Lamas, Ruth Stuckey, alberto Alvarez-Larran, María Alicia Senin, Elvira Mora Casterá, Paula Sastre, Maria Laura Fox, Irene Pastor Galan, María Teresa Gómez Casares, Gemma Azaceta, Sara Garrido Paniagua, Raul Perez Lopez, Diana Margarita Trejos Carvajal, Anna Angona, Carmen Albo Lopez, Pablo Lorente, Regina Garcia Delgado, Míriam Vara Pampliega, Juan Antonio Juan Vera Goñi, Dunia De Miguel Llorente, Angeles Fernández Rodríguez, Alberto Marin Sanchez, Adriana Hernando Megido, Gonzalo Carreño, Natalia De Las Heras Rodriguez, Blanca Xicoy, Manuel Perez Encinas, Raquel Mata Serna, Lucia Nuñez Martin-Buitrago, Francisca Ferrer Marin, Neus Amer Salas, Carolina Guillén Rienda, Patricia Velez, Laura Lamarca Eraso, Sandra Martín, Iryna Luts Khoroz, Abel Domingo, Erik De Cabo López, Angela Gil, Sofía Martín-Consuegra Ramos, Fernando Marco De Lucas, Maria José Otero Martinez-Fornes, María Luisa Martín Mateos, Teresa Arquero-Portero, Luis Antonio López Gómez, Angela Martinez Hellin, Aurelia Tejedor, Esther Herrera de Pablo, Maria Isabel Mata Vazquez, Inmaculada Castillo Valero, Maria Jose Fernández, Carlos Aguilar-Franco, Marta Santaliestra, Antonio Garcia Menchon, Begona Navas Elorza, Maria Antonia Duran, María Pérez Sala, Teresa Hernández Santamaría, Mª Ángeles Muñoz Jarreño, Julio Davila Valls, Williana Torres Jiménez, Joan Alfons Gonzálvez Fernández, Teresa Cobo, Aitor Abuin Blanco, Francisco Pérez, Maria José Llácer Ferrandis, Paola Beneit Villena, Raisa Peralta, Federico Herrera, Eloi Cañamero Giro, Reyes Jimenez Barcenas, Mercedes Gasior Kabat, Sonia González De Villambrosia, Marina Menéndez Cuevas, Beatriz Cuevas Ruiz, Marta Fonseca-Santos, Sonia Garcés Piquer, Rosalía Delapuerta, Alvaro Lorenzo Vizcaya, Juan Carlos Hernandez Boluda, Valentín García Gutiérrez

Blood (2025) 146 (Supplement 1): 3808.

https://doi.org/10.1182/blood-2025-3808

Published: 2025

Journal Articles

Ponatinib as a consolidation strategy for a second attempt at TKI discontinuation in chronic myeloid leukemia: Interim results from the restop Trial

Almudena Zaratiegui Vergara, Gonzalo Carreño, Francisca Ferrer Marin, Blanca Xicoy, María Teresa Gómez Casares, Fermin Sanchez-Guijo, M Concepción Ruiz Nuño, Santiago Osorio Prendes, Raquel De Paz, Ana Isabel Rosell Mas, Elvira Mora Casterá, María Alicia Senin, Juan Carlos Hernandez Boluda, Rosa Ayala Diaz, Valentín García Gutiérrez, Joaquin Martinez Lopez

Blood (2025) 146 (Supplement 1): 3778.

https://doi.org/10.1182/blood-2025-3778

Published: 2025

Journal Articles

Pre-transplant physical function and sarcopenia assessment in allogeneic stem cell transplant recipients: A cross-sectional analysis from a multidisciplinary program

Blood (2025) 146 (Supplement 1): 7792.

https://doi.org/10.1182/blood-2025-7792

Published: 2025

Journal Articles

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Aniket Bankar, Andrew Kuykendall, Naveen Pemmaraju, Kristen Pettit, Joseph Shatzel, Alessandro Lucchesi, Valentín García Gutiérrez, Harinder Gill, Joseph Scandura, Francesca Palandri, Matthew Reaney, Cristina Ivanescu, Christina Daskalopoulou, Phil Dinh, Sarita Khanna, Suneel Gupta, Arturo Molina, David Cella

Blood (2025) 146 (Supplement 1): 5588.

https://doi.org/10.1182/blood-2025-5588

Published: 2025

Journal Articles

Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure

Joseph Shatzel, Andrew Kuykendall, Aniket Bankar, Naveen Pemmaraju, Kristen Pettit, Alessandro Lucchesi, Valentín García Gutiérrez, Antonieta Sosa, A. Peter Morello, Pedro Oyuela, Phil Dinh, Arturo Molina

Blood (2025) 146 (Supplement 1): 5587.

https://doi.org/10.1182/blood-2025-5587

Published: 2025

Journal Articles

Clinical, Biological and Prognostic Characterization of Multiple Myeloma According to the Presence of Circulating Plasma Cells

Beatriz Astibia Mahillo, María-Jesús Blanchard, Miguel Piris Villaespesa, Pablo Palomo Rumschisky, Jesús Villarrubia Espinosa, Valentín García Gutiérrez, Sr., Ana Jiménez, Mónica García-Cosío, Ernesto Roldán Santiago, Eulalia Rodríguez Martín, María Talavera Yagüez, Gemma Moreno Jiménez, Javier López, Fernando Martín Moro

Blood (2024) 144 (Supplement 1): 3349.

https://doi.org/10.1182/blood-2024-210589

Published: 2024

Journal Articles

Combination of Minimal Residual Disease By Flow Cytometry before and after Hematopoietic Stem Cell Transplantation Predicts Survival in Patients with Acute Myeloid Leukemia

Claudia Nuñez-Torron stock, Carlos Jiménez, Fernando Martín Moro, Juan Marquet, Miguel Piris-Villaespesa, Clara Lopez Hernandez, Alejandro Luna, Valentín García Gutiérrez, Sr., Anabelle Chinea, Maria Gemma Moreno Jimenez, Javier López, Pilar Herrera Puente

Blood (2024) 144 (Supplement 1): 7445.

https://doi.org/10.1182/blood-2024-210576

Published: 2024

Journal Articles

Clinical Impact of Colonization By Multi-Drug Resistant Organisms in Stem Cell Transplantation

Lucia Bolea, Alejandro Luna, Enrique Blanco, Valentín García Gutiérrez, Sr., Anabelle Chinea, Begoña Hijono, Maria Luisa Palacios-Berraquero, Pablo Palomo Rumschisky, Blanca De Felipe, Lucía Pérez-Lamas, Carlos Jiménez, Beatriz Astibia Mahillo, Alejandro Zurdo-Castronuño, Maria Piñero, Rut Corrales, Pilar Herrera, Javier López

Blood (2024) 144 (Supplement 1): 3491.

https://doi.org/10.1182/blood-2024-206026

Published: 2024

Journal Articles

Observational, Retrospective and Multicenter Analysis of Spanish CML Group , in Patients with Chronic Myeloid Leukemia in Treatment-Free Remission after Discontinuation of Bosutinib

Gonzalo Maortua Langdon, Raquel De Paz, Pilar Giraldo, Blanca Xicoy, Joaquin Martinez Lopez, Guiomar Bautista Carrascosa, Jose Maria Alonso Alonso, Maria Soledad Noya Pereira, Magdalena Sierra Pacho, Raul Perez Lopez, Silvana Daniela Saavedra Gerosa, Valle Gomez G De Soria, Natalia De Las Heras, Valentín García Gutiérrez, Sr.

Blood (2024) 144 (Supplement 1): 6604.

https://doi.org/10.1182/blood-2024-208460

Published: 2024

Journal Articles

Prevalence and Characteristics of Cutaneous Mastocytosis in Adult-Onset Mastocytosis in the Skin

Pablo Palomo Rumschisky, Lucia Bolea, Blanca De Felipe, Beatriz Astibia Mahillo, Fernando Martín Moro, Jesus Villarrubia Espinosa, Valentín García Gutiérrez, Sr., Ander Arteagoitia, Monica Garcia-Cosio, David González-De-Olano, Asunción Ballester, Bibiana Pérez García, Almudena Santón, Laura Carpio, Pilar Herrera Puente, Maria Gemma Moreno Jimenez, Javier López, Miguel Piris-Villaespesa

Blood (2024) 144 (Supplement 1): 6654.

https://doi.org/10.1182/blood-2024-202097

Published: 2024

Journal Articles

ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

Blood (2024) 144 (Supplement 1): 6635.

https://doi.org/10.1182/blood-2024-199028

Published: 2024

Journal Articles

Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 3149.

https://doi.org/10.1182/blood-2024-205681

Published: 2024

Journal Articles

Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia

Lucía Pérez-Lamas, Adrian Segura Diaz, Regina García Delgado, Alberto Alvarez-Larran, María Alicia Senin, Elvira Mora, Maria Laura Fox, Irene Pastor Galan, Gemma Azaceta, Sara Garrido Paniagua, Raul Perez Lopez, Diana Margarita Trejos Carvajal, Anna Angona, Carmen Albo Lopez, Pablo Lorente Alegre, Míriam Vara, Juan Antonio Juan Vera Goñi, Dunia De Miguel Llorente, Angeles Fernández Rodríguez, Alberto Marin Sanchez, Adriana Hernando Megido, Maria Teresa Gómez Casares, Ruth Stuckey, Gonzalo Carreño, Natalia De Las Heras Rodriguez, Blanca Xicoy, Manuel Perez Encinas, Raquel Mata Serna, Lucia Nuñez Martin-Buitrago, Francisca Ferrer Marin, Neus Amer Salas, Carolina Guillén Rienda, Patricia Velez, Laura Lamarca Eraso, Sandra Martín, Iryna Luts Khoroz, Erik De Cabo López, Angela Gil, Sofía Martín-Consuegra Ramos, Fernando Marco De Lucas, Maria José Otero Martinez-Fornes, María Luisa Martín Mateos, Teresa Arquero, Elena Cabezudo Pérez, Luis Antonio López Gómez, Angela Martinez Hellin, Aurelia Tejedor, Esther Herrera de Pablo, Maria Isabel Mata Vazquez, Inmaculada Castillo Valero, Maria Jose Fernández, Carlos Aguilar, Marta Santaliestra, Antonio Garcia Menchon, Begona Navas Elorza, Maria Antonia Duran, María Pérez Sala, Teresa Hernández Santamaría, Mª Ángeles Muñoz Jarreño, Julio Dávila-Valls, Williana Torres Jiménez, Joan Alfons Gonzálvez Fernández, Hugo Alexander Torres Mantilla, Teresa Cobo Rodríguez, Aitor Abuin Blanco, Francisco Pérez, María José Llácer Ferrandis, Paola Beneit Villena, Raisa Peralta, Federico Herrera, Eloi Cañamero Giro, Reyes Jimenez Barcenas, Mercedes Gasior Kabat, Sonia González De Villambrosia, Mariana Teresa Tercero-Mora Rodriguez, Marina Menéndez Cuevas, Beatriz Cuevas Ruiz, Marta Fonseca-Santos, Sonia Garcés Piquer, Rosalía Delapuerta, Alvaro Lorenzo Vizcaya, Juan Carlos Hernandez Boluda, Valentín García Gutiérrez, Sr.

Blood (2024) 144 (Supplement 1): 1790.

https://doi.org/10.1182/blood-2024-200698

Published: 2024

Journal Articles

Prognostic Value of Response to First-Line Hydroxyurea According to Ipset Stratification in Essential Thrombocythemia

Blood (2024) 144 (Supplement 1): 241.

https://doi.org/10.1182/blood-2024-198336

Published: 2024

Journal Articles

Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience

Elias Jabbour, Delphine Rea, Mouna Bardey-Kanaan, Romuald Soichez, Nhan Thanh Nguyen, Deborah Kelly, Federica Rizzo, Petros Patos, Valentín García Gutiérrez, Sr.

Blood (2024) 144 (Supplement 1): 3816.

https://doi.org/10.1182/blood-2024-200256

Published: 2024

Journal Articles

Experienced or Perceived Burdens and Associated Quality of Life Impacts of Anemia and Transfusion Dependence in Myelofibrosis: A Patient Self-Report Survey Analysis

Thomas W. LeBlanc, Hannah Collacott, Valentín García Gutiérrez, Sr., Ned Weinshenker, Ruth Fein Revell, Alicia O'Neill, Anna P Cardellino, Shiyuan Zhang, Dwaipayan Patnaik, Melissa Ross

Blood (2024) 144 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2024-206086

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study

The recombinant adjuvant zoster vaccine induces similar immune responses in ruxolitinib-treated patients with myelofibrosis and polycythemia vera

Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study

Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics

Molecular predictors of anemia response to momelotinib in patients with myelofibrosis: Real-world outcomes from the momgemfin study.

Ponatinib as a consolidation strategy for a second attempt at TKI discontinuation in chronic myeloid leukemia: Interim results from the restop Trial

Pre-transplant physical function and sarcopenia assessment in allogeneic stem cell transplant recipients: A cross-sectional analysis from a multidisciplinary program

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure

Clinical, Biological and Prognostic Characterization of Multiple Myeloma According to the Presence of Circulating Plasma Cells

Combination of Minimal Residual Disease By Flow Cytometry before and after Hematopoietic Stem Cell Transplantation Predicts Survival in Patients with Acute Myeloid Leukemia

Clinical Impact of Colonization By Multi-Drug Resistant Organisms in Stem Cell Transplantation

Observational, Retrospective and Multicenter Analysis of Spanish CML Group , in Patients with Chronic Myeloid Leukemia in Treatment-Free Remission after Discontinuation of Bosutinib

Prevalence and Characteristics of Cutaneous Mastocytosis in Adult-Onset Mastocytosis in the Skin

ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options

Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia

Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia

Prognostic Value of Response to First-Line Hydroxyurea According to Ipset Stratification in Essential Thrombocythemia

Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience

Experienced or Perceived Burdens and Associated Quality of Life Impacts of Anemia and Transfusion Dependence in Myelofibrosis: A Patient Self-Report Survey Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only